Viatris Inc. (VTRS) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 23, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 6, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the VTRS SEC filings page.
Viatris Inc. (VTRS) reported $14.7B in revenue over the twelve months to Jun 30, 2026, up 4.4% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 8 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Viatris remains cash-generative despite a severe accounting loss, while weaker margins and shrinking equity reveal a more pressured operating model.
Operating cash flow was$2.3B in FY2025, nearly unchanged from FY2024 despite a net loss of$3.5B . With depreciation and amortization at$2.8B , the gap indicates reported earnings were heavily separated from cash economics.
Revenue fell while cost of revenue rose, making the contraction a cost squeeze rather than merely a volume effect. Gross margin fell
Long-term debt fell
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Viatris Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Viatris Inc. has an operating margin of -18.6%, meaning the company loses $19 on every $100 of revenue. This results in a profitability score of 17/100. This is down from 0.1% the prior year.
Viatris Inc.'s revenue declined 3.0% year-over-year, from $14.7B to $14.3B. This contraction results in a growth score of 19/100.
Viatris Inc. has elevated debt relative to equity (D/E of 0.85), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 1/100, reflecting increased financial risk.
Viatris Inc.'s current ratio of 1.38 indicates adequate short-term liquidity, earning a score of 37/100. The company can meet its near-term obligations, though with limited headroom.
Viatris Inc. converts 13.6% of revenue into free cash flow ($1.9B). This strong cash generation earns a score of 76/100.
Viatris Inc. posts a -23.9% return on equity (ROE), meaning it loses $24 for every $100 of shareholders' equity. This results in a returns score of 18/100. This is down from -3.4% the prior year.
Viatris Inc. scores 0.77, below the 1.81 distress threshold. The score is pulled down most by an operating loss of $2.7B against total assets of $37.2B. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Viatris Inc. passes 5 of 9 financial strength tests. 2 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, 1 of 2 operating efficiency signals passes.
Viatris Inc. reported a net loss of $3.5B while generating $2.3B in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.
Viatris Inc. reported an operating loss of $2.7B against $471.3M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
Viatris Inc. generated $3.8B in revenue in Q2 2026. This represents an increase of 4.9% from the same quarter a year earlier. Against the prior quarter it is up 6.8%.
Viatris Inc.'s EBITDA was $678.6M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 25.5% from the same quarter a year earlier. Against the prior quarter it is up 13.8%.
Viatris Inc. reported a net loss of $118.8M in Q2 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. Against the prior quarter it is down 167.3%.
Viatris Inc. earned -$0.10 per diluted share (EPS) in Q2 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. Against the prior quarter it is down 166.7%.
Cash & Balance Sheet
Viatris Inc. generated $329.0M in free cash flow in Q2 2026, representing cash available after capex. This represents an increase of 97.2% from the same quarter a year earlier. Against the prior quarter it is down 5.6%.
Viatris Inc. held $886.5M in cash against $11.6B in long-term debt as of Q2 2026.
Viatris Inc. paid $0.12 per share in dividends in Q2 2026. That is unchanged from the same quarter a year earlier. It is unchanged from the prior quarter.
Margins & Returns
Viatris Inc.'s gross margin was 38.8% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 1.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 5.9 percentage points.
Viatris Inc.'s operating margin was 0.2% in Q2 2026, reflecting core business profitability. This is down 6.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.4 percentage points.
Viatris Inc.'s net profit margin was -3.2% in Q2 2026, showing the share of revenue converted to profit. This is down 3.0 percentage points from the same quarter a year earlier. Against the prior quarter it is down 8.2 percentage points.
Viatris Inc.'s quarterly ROE was -0.8% in Q2 2026: one quarter's net income over shareholder equity, not annualized. This is down 0.8 percentage points from the same quarter a year earlier. Against the prior quarter it is down 2.0 percentage points.
Capital Allocation
Viatris Inc. invested $248.3M in research and development in Q2 2026. This represents an increase of 13.5% from the same quarter a year earlier. Against the prior quarter it is down 0.1%.
Viatris Inc. spent $150.0M on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 14.3% from the same quarter a year earlier. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Viatris Inc. invested $52.8M in capex in Q2 2026, funding long-term assets and infrastructure. This represents a decrease of 0.2% from the same quarter a year earlier. Against the prior quarter it is up 32.3%.
VTRS Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.8B+4.9% | $3.5B+8.1% | $3.7B+5.0% | $3.8B+0.2% | $3.6B-5.6% | $3.3B-11.2% | $3.5B-8.1% | $3.8B-4.8% |
| Cost of Revenue | $2.3B+2.3% | $2.4B+12.7% | $2.6B+10.5% | $2.4B+4.2% | $2.2B-4.3% | $2.1B-3.1% | $2.3B+3.2% | $2.3B+1.8% |
| Gross Profit | $1.5B+9.3% | $1.2B-0.3% | $1.1B-5.5% | $1.4B-6.0% | $1.3B-7.8% | $1.2B-22.8% | $1.2B-23.9% | $1.5B-13.7% |
| R&D Expenses | $248.3M+13.5% | $248.6M+12.0% | $274.7M+33.0% | $250.4M+26.2% | $218.8M+7.2% | $222.0M+11.2% | $206.5M+1.8% | $198.4M-6.1% |
| SG&A Expenses | $1.1B+22.2% | $928.8M-2.0% | $1.0B-1.5% | $886.6M-11.6% | $928.7M-10.4% | $948.1M-6.8% | $1.0B+2.0% | $1.0B-4.8% |
| Operating Income | $6.3M-97.3% | -$79.7Mn/m | -$192.7Mn/m | $178.8M-20.8% | $233.0Mn/m | -$2.9B-1513.5% | -$179.8Mn/m | $225.9M-50.0% |
| EBITDA | $678.6M-25.5% | $596.4Mn/m | $574.1M+1.4% | $867.3M-3.2% | $911.3M+66.8% | -$2.2B-347.8% | $566.4M+198.3% | $895.6M-20.8% |
| Interest Expense | $120.7M+3.5% | $120.1M+4.0% | $119.6M-0.5% | $119.6M-17.9% | $116.6M-20.0% | $115.5M-16.5% | $120.2M-14.7% | $145.6M+2.9% |
| Income Tax | $54.8Mn/m | -$423.7Mn/m | -$2.9Mn/m | $120.3Mn/m | -$212.5Mn/m | -$55.0M-160.6% | -$10.0Mn/m | -$4.3M-106.1% |
| Net Income | -$118.8Mn/m | $176.4Mn/m | -$340.1Mn/m | -$128.2M-235.2% | -$4.6Mn/m | -$3.0B-2770.8% | -$516.5Mn/m | $94.8M-71.4% |
| EPS (Basic) | -$0.10n/m | $0.15n/m | -$0.30n/m | -$0.11-237.5% | $0.00n/m | -$2.55-2650.0% | -$0.43n/m | $0.08-71.4% |
| EPS (Diluted) | -$0.10n/m | $0.15n/m | -$0.30n/m | -$0.11-237.5% | $0.00n/m | -$2.55-2933.3% | -$0.43n/m | $0.08-70.4% |
| Diluted Shares (Avg) | 1.16B-0.8% | 1.18B-1.4% | N/A | 1.16B-3.0% | 1.17B-1.5% | 1.19B-1.4% | N/A | 1.20B-0.6% |
VTRS Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $35.0B-8.8% | $36.8B-4.3% | $37.2B-10.4% | $37.9B-15.3% | $38.4B-15.3% | $38.5B-18.7% | $41.5B-13.0% | $44.8B-8.2% |
| Current Assets | $10.1B+2.9% | $10.9B+13.5% | $9.8B+2.8% | $10.0B-12.0% | $9.8B-17.1% | $9.6B-25.5% | $9.5B-26.6% | $11.3B+3.4% |
| Cash & Equivalents | $886.5M+56.5% | $1.8B+139.0% | $1.3B+80.0% | $975.3M-48.1% | $566.4M-38.2% | $755.0M-25.6% | $734.8M-25.9% | $1.9B+43.5% |
| Short-Term Investments | $0n/m | $0n/m | $40.7M+7.1% | $0n/m | $0n/m | $0n/m | $38.0M+2.7% | $0n/m |
| Inventory | $3.9B-7.8% | $3.9B-4.1% | $4.0B+3.8% | $4.1B+0.7% | $4.3B+8.2% | $4.1B+7.1% | $3.9B+11.1% | $4.1B+11.2% |
| Accounts Receivable | $3.1B-4.0% | $3.1B-1.6% | $3.0B-5.9% | $3.4B-9.3% | $3.3B-8.7% | $3.1B-13.9% | $3.2B-12.9% | $3.7B-0.6% |
| Long-Term Investments | $0n/m | $0n/m | N/A | $0n/m | $0n/m | $0n/m | N/A | $0n/m |
| Goodwill | $6.7B-1.4% | $6.7B+3.6% | $6.8B-26.0% | $6.7B-29.6% | $6.7B-27.6% | $6.5B-33.3% | $9.1B-7.4% | $9.6B-7.0% |
| Total Liabilities | $20.8B-9.0% | $22.2B-2.8% | $22.5B-1.7% | $22.7B-9.0% | $22.8B-11.5% | $22.8B-16.5% | $22.9B-16.0% | $25.0B-10.5% |
| Current Liabilities | $6.3B-11.0% | $6.8B+19.1% | $7.1B+22.8% | $7.4B-2.0% | $7.1B-7.5% | $5.7B-26.3% | $5.8B-25.7% | $7.5B+9.9% |
| Non-Current Liabilities | $14.4B-8.1% | $15.4B-10.2% | $15.4B-9.9% | $15.3B-12.1% | $15.7B-13.2% | $17.1B-12.6% | $17.1B-12.1% | $17.4B-17.1% |
| Long-Term Debt | $11.6B-9.2% | $12.4B-12.4% | $12.5B-11.1% | $12.5B-12.7% | $12.8B-13.2% | $14.2B-11.8% | $14.0B-13.3% | $14.3B-16.2% |
| Total Equity | $14.3B-8.4% | $14.7B-6.3% | $14.7B-21.1% | $15.2B-23.1% | $15.6B-20.2% | $15.7B-21.8% | $18.6B-9.0% | $19.8B-5.1% |
| Retained Earnings | -$330.7M-513.4% | -$211.9M-193.0% | -$388.3M-111.4% | -$48.2M-101.2% | $80.0M-98.1% | $227.9M-95.1% | $3.4B-26.3% | $4.1B-26.5% |
VTRS Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $381.8M+73.8% | $388.3M-27.5% | $815.8M+69.0% | $744.9M-9.9% | $219.7M-42.0% | $535.5M-12.9% | $482.7M-15.1% | $826.5M-1.0% |
| Depreciation & Amortization | $672.3M-0.9% | $676.1M+1.7% | $766.8M+2.8% | $688.5M+2.8% | $678.3M-13.7% | $664.7M-3.8% | $746.2M+15.8% | $669.7M-1.4% |
| Stock-Based Compensation | N/A | $48.2M-12.7% | N/A | N/A | N/A | $55.2M+18.2% | N/A | N/A |
| Capital Expenditures | $52.8M-0.2% | $39.9M-6.3% | $196.5M+40.0% | $86.8M+12.7% | $52.9M-10.0% | $42.6M-14.5% | $140.4M-15.2% | $77.0M-19.7% |
| Free Cash Flow | $329.0M+97.2% | $348.4M-29.3% | $619.3M+80.9% | $658.1M-12.2% | $166.8M-47.9% | $492.9M-12.7% | $342.3M-15.1% | $749.5M+1.4% |
| Investing Cash Flow | -$51.6Mn/m | $277.4Mn/m | -$211.2Mn/m | -$98.9M-105.7% | -$52.5M-114.0% | -$65.1Mn/m | -$168.7M-731.8% | $1.7Bn/m |
| Financing Cash Flow | -$1.2Bn/m | -$203.8Mn/m | -$236.4Mn/m | -$228.1Mn/m | -$362.4Mn/m | -$467.0Mn/m | -$1.4Bn/m | -$1.6Bn/m |
| Share Buybacks | $150.0M-14.3% | $0-100.0% | $85.1Mn/m | $67.9Mn/m | $175.0Mn/m | $175.4M-29.8% | $0n/m | $0n/m |
Not reported in any period shown, so not listed: Dividends Paid.
VTRS Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 38.8%+1.6pp | 32.9%-2.8pp | 31.0%-3.4pp | 36.5%-2.4pp | 37.2%-0.9pp | 35.7%-5.4pp | 34.4%-7.2pp | 38.9%-4.0pp |
| Operating Margin | 0.2%-6.3pp | -2.3%+86.3pp | -5.2%-0.1pp | 4.8%-1.3pp | 6.5%+12.8pp | -88.6%-94.1pp | -5.1%+6.7pp | 6.0%-5.4pp |
| Net Margin | -3.2%-3.0pp | 5.0%+98.5pp | -9.2%+5.5pp | -3.4%-5.9pp | -0.1%+8.5pp | -93.5%-96.6pp | -14.6%+5.3pp | 2.5%-5.9pp |
| Return on Equity | -0.8%-0.8pp | 1.2%+20.6pp | -2.3%+0.5pp | -0.8%-1.3pp | 0.0%+1.6pp | -19.4%-20.0pp | -2.8%+1.0pp | 0.5%-1.1pp |
| Return on Assets | -0.3%-0.3pp | 0.5%+8.4pp | -0.9%+0.3pp | -0.3%-0.5pp | 0.0%+0.7pp | -7.9%-8.2pp | -1.2%+0.4pp | 0.2%-0.5pp |
| Current Ratio | 1.58+0.2x | 1.60-0.1x | 1.38-0.3x | 1.35-0.2x | 1.37-0.2x | 1.680.0x | 1.650.0x | 1.51-0.1x |
| Debt-to-Equity | 0.810.0x | 0.85-0.1x | 0.85+0.1x | 0.82+0.1x | 0.82+0.1x | 0.91+0.1x | 0.750.0x | 0.72-0.1x |
| Liabilities-to-Equity | 1.460.0x | 1.51+0.1x | 1.53+0.3x | 1.49+0.2x | 1.47+0.1x | 1.46+0.1x | 1.23-0.1x | 1.26-0.1x |
| Asset Turnover | 0.110.0x | 0.100.0x | 0.100.0x | 0.100.0x | 0.090.0x | 0.080.0x | 0.090.0x | 0.080.0x |
| FCF Margin | 8.8%+4.1pp | 9.9%-5.2pp | 16.7%+7.0pp | 17.5%-2.5pp | 4.7%-3.8pp | 15.2%-0.3pp | 9.7%-0.8pp | 20.0%+1.2pp |
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Viatris Inc. VTRS | FY2025 | $14.3B | -$3.5B | -24.6% | $20.7B | 28/100 |
| Dr. Reddy's Laboratories Limited RDY | FY2026 | $3.6B | $452.0M | 12.6% | $11.0B | 64/100 |
| Teva Pharmaceutical Industries Limited TEVA | FY2025 | $17.3B | $1.4B | 8.2% | $46.0B | 34/100 |
| Neurocrine Biosciences Inc NBIX | FY2025 | $2.9B | $478.6M | 16.7% | $14.5B | 79/100 |
| United Therapeutics Corp UTHR | FY2025 | $3.2B | $1.3B | 41.9% | $25.2B | 88/100 |
| Elanco Animal Health Incorporated ELAN | FY2025 | $4.7B | -$232.0M | -4.9% | $11.3B | 43/100 |
Where Viatris Inc. Ranks
Frequently Asked Questions
What is Viatris Inc.'s annual revenue?
Viatris Inc. (VTRS) reported $14.3B in total revenue for fiscal year 2025. This represents a -3.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Viatris Inc.'s revenue growing?
Viatris Inc. (VTRS) revenue declined by 3.0% year-over-year, from $14.7B to $14.3B in fiscal year 2025.
Is Viatris Inc. profitable?
No, Viatris Inc. (VTRS) reported a net loss of $410.7M over the trailing 12 months to June 30, 2026. In fiscal year 2025 it reported a net loss of $3.5B, with a net profit margin of -24.6%.
What is Viatris Inc.'s EBITDA?
Viatris Inc. (VTRS) had EBITDA of $135.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Viatris Inc. have?
As of fiscal year 2025, Viatris Inc. (VTRS) had $1.3B in cash and equivalents against $12.5B in long-term debt.
What is Viatris Inc.'s gross margin?
Viatris Inc. (VTRS) had a gross margin of 35.1% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Viatris Inc.'s operating margin?
Viatris Inc. (VTRS) had an operating margin of -18.6% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Viatris Inc.'s net profit margin?
Viatris Inc. (VTRS) had a net profit margin of -24.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
Does Viatris Inc. pay dividends?
Yes, Viatris Inc. (VTRS) paid $0.48 per share in dividends during fiscal year 2025.
What is Viatris Inc.'s return on equity (ROE)?
Viatris Inc. (VTRS) has a return on equity of -23.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Viatris Inc.'s free cash flow?
Viatris Inc. (VTRS) generated $1.9B in free cash flow during fiscal year 2025. This represents a -2.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Viatris Inc.'s operating cash flow?
Viatris Inc. (VTRS) generated $2.3B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Viatris Inc.'s total assets?
Viatris Inc. (VTRS) had $37.2B in total assets as of fiscal year 2025, including both current and long-term assets.
What are Viatris Inc.'s capital expenditures?
Viatris Inc. (VTRS) invested $378.8M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Viatris Inc. spend on research and development?
Viatris Inc. (VTRS) invested $965.9M in research and development during fiscal year 2025.
What is Viatris Inc.'s current ratio?
Viatris Inc. (VTRS) had a current ratio of 1.38 as of fiscal year 2025, which is considered adequate.
What is Viatris Inc.'s debt-to-equity ratio?
Viatris Inc. (VTRS) had a debt-to-equity ratio of 0.85 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.
What is Viatris Inc.'s liabilities-to-equity ratio?
Viatris Inc. (VTRS) had a liabilities-to-equity ratio of 1.53 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.
What is Viatris Inc.'s return on assets (ROA)?
Viatris Inc. (VTRS) had a return on assets of -9.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Viatris Inc.'s P/E ratio?
Viatris Inc. (VTRS) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2026). The market capitalization is $20.7B as of Oct 23, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Viatris Inc.'s price-to-sales ratio?
Viatris Inc. (VTRS) trades at 1.4x sales, its market capitalization divided by $14.7B revenue, trailing 12 months to June 30, 2026. The market capitalization is $20.7B as of Oct 23, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Viatris Inc.'s Altman Z-Score?
Viatris Inc. (VTRS) has an Altman Z-Score of 0.77, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Viatris Inc.'s Piotroski F-Score?
Viatris Inc. (VTRS) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Viatris Inc.'s earnings high quality?
Viatris Inc. (VTRS) reported a net loss of $3.5B while generating $2.3B in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Viatris Inc. cover its interest payments?
Viatris Inc. (VTRS) reported an operating loss of $2.7B against $471.3M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Viatris Inc.?
Viatris Inc. (VTRS) scores 28 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.